Pfizer leaps more than 7% after releasing positive trial results for coronavirus vaccine

Business Insider

Published

· *Pfizer shares soared as much as 7.2% on Wednesday after the company announced positive early-stage trial results for its coronavirus vaccine.*
· *The BNT162b1 drug successfully created antibodies in all participants receiving 10, 30, or 100 microgram doses. *
· *Those taking two of the 10 or 30 microgram doses created...

Full Article